Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Common Stock | Award | $6.19M | +7.12K | +32.92% | $868.88 | 28.8K | Feb 10, 2025 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Restricted Stock Unit | Award | $0 | +3.39K | $0.00 | 3.39K | Feb 10, 2025 | Common Stock | 3.39K | Direct | F1 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |